Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

BERLIN (Reuters) -Roche has entered an exclusive collaboration and licensing agreement with Danish obesity drug maker Zealand ...

Merck said the facility, which had a ribbon cutting Tuesday, is a 225,000-square-foot state-of-the-art plant, officials said.

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz. facilities and is working on a written response.

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...

Stephen Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck ...

The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more af ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of ...